Document is current
Any future updates will be listed below
-
Authors
Shin, Kyong-Oh
Crumrine, Debra A.
Kim, Sungeun
Lee, Yerin
Kim, Bogyeong
Abuabara, Katrina
Park, Chaehyeong
Uchida, Yoshikazu
Wakefield, Joan S.
Meyer, Jason M.
Jeong, Sekyoo
Park, Byeong Deog
Park, Kyungho
Elias, Peter M. http://orcid.org/0000-0001-7989-4032
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 AR061106)
Hallym University (H20180060)
- License Information
-
More Information
Article History
Received: 23 June 2020
Accepted: 1 June 2021
First Online: 22 June 2021
Declarations
:
: All animal procedures were subjected to approval by the Ethical Committee on Animal Experiments, Hallym University, Korea (permit number: Hallym-2018-84) and performed accordingly.
: Not available.
: Dr. B.D. Park is CEO of SphingoBrain Inc., San Francisco, CA, which has a pending patent application (US15981669) related to the diagnosis and amelioration of atopic dermatitis-associated autism spectrum disorders; Dr. Elias is a non-paid consultant to SphingoBrain. None of the authors have any non-financial conflicts of interest.
